These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 10823292)

  • 1. Does increasing dose improve efficacy in patients with poor antidepressant response: a review.
    Corruble E; Guelfi JD
    Acta Psychiatr Scand; 2000 May; 101(5):343-8. PubMed ID: 10823292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sponsorship, antidepressant dose, and outcome in major depressive disorder: meta-analysis of randomized controlled trials.
    Sinyor M; Schaffer A; Smart KA; Levitt AJ; Lanctôt KL; Grysman NH
    J Clin Psychiatry; 2012 Feb; 73(2):e277-87. PubMed ID: 22401489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy, safety and tolerability of duloxetine 60 mg once daily in major depression.
    Cowen PJ; Ogilvie AD; Gama J
    Curr Med Res Opin; 2005 Mar; 21(3):345-56. PubMed ID: 15811202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for the benefits of nonantipsychotic pharmacological augmentation in the treatment of depression.
    Chang CM; Sato S; Han C
    CNS Drugs; 2013 May; 27 Suppl 1():S21-7. PubMed ID: 23712796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological treatment of adolescent major depression.
    Cohen D; Gerardin P; Mazet P; Purper-Ouakil D; Flament MF
    J Child Adolesc Psychopharmacol; 2004; 14(1):19-31. PubMed ID: 15142388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants].
    Leblé N; Radon L; Rabot M; Godart N
    Encephale; 2017 Feb; 43(1):62-68. PubMed ID: 27452149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressants for depression in stage 3-5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP).
    Nagler EV; Webster AC; Vanholder R; Zoccali C
    Nephrol Dial Transplant; 2012 Oct; 27(10):3736-45. PubMed ID: 22859791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression.
    Thomas SJ; Shin M; McInnis MG; Bostwick JR
    Pharmacotherapy; 2015 Apr; 35(4):433-49. PubMed ID: 25884531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vilazodone for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
    Citrome L
    Int J Clin Pract; 2012 Apr; 66(4):356-68. PubMed ID: 22284853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
    Cipriani A; Furukawa TA; Salanti G; Chaimani A; Atkinson LZ; Ogawa Y; Leucht S; Ruhe HG; Turner EH; Higgins JPT; Egger M; Takeshima N; Hayasaka Y; Imai H; Shinohara K; Tajika A; Ioannidis JPA; Geddes JR
    Lancet; 2018 Apr; 391(10128):1357-1366. PubMed ID: 29477251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging drugs for major depressive disorder.
    Connolly KR; Thase ME
    Expert Opin Emerg Drugs; 2012 Mar; 17(1):105-26. PubMed ID: 22339643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant dose reduction and the risk of relapse in major depressive disorder.
    Papakostas GI; Perlis RH; Seifert C; Fava M
    Psychother Psychosom; 2007; 76(5):266-70. PubMed ID: 17700046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of desvenlafaxine 50 mg/d for treating MDD: a review of two randomized placebo-controlled trials for the practicing physician.
    Reddy S; Kane C; Pitrosky B; Musgnung J; Ninan PT; Guico-Pabia CJ
    Curr Med Res Opin; 2010 Jan; 26(1):139-50. PubMed ID: 19919295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for switching antidepressants to achieve maximum efficacy adolescents.
    Jefferson JW
    J Clin Psychiatry; 2008; 69 Suppl E1():14-8. PubMed ID: 18494539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-response relationship of recent antidepressants in the short-term treatment of depression.
    Berney P
    Dialogues Clin Neurosci; 2005; 7(3):249-62. PubMed ID: 16156383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-frequency repetitive transcranial magnetic stimulation accelerates and enhances the clinical response to antidepressants in major depression: a meta-analysis of randomized, double-blind, and sham-controlled trials.
    Berlim MT; Van den Eynde F; Daskalakis ZJ
    J Clin Psychiatry; 2013 Feb; 74(2):e122-9. PubMed ID: 23473357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The search for improved antidepressant strategies: is bigger better?
    Coryell W
    Am J Psychiatry; 2011 Jul; 168(7):664-6. PubMed ID: 21724669
    [No Abstract]   [Full Text] [Related]  

  • 18. Antidepressants in child and adolescent depression: where are the bugs?
    Moreno C; Arango C; Parellada M; Shaffer D; Bird H
    Acta Psychiatr Scand; 2007 Mar; 115(3):184-95. PubMed ID: 17302618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterizing the ideal antidepressant therapy to achieve remission.
    Ferrier IN
    J Clin Psychiatry; 2001; 62 Suppl 26():10-5. PubMed ID: 11775087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and tolerability of antidepressant co-treatment in acute major depressive disorder: results from a systematic review and exploratory meta-analysis.
    Galling B; Calsina Ferrer A; Abi Zeid Daou M; Sangroula D; Hagi K; Correll CU
    Expert Opin Drug Saf; 2015 Oct; 14(10):1587-608. PubMed ID: 26360500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.